Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Acute Kidney Injury Treatment Market: By Type: Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Others; By Treatment: Dialysis, Supportive Care; By End Use: Hospitals, Ambulatory Surgical Centres; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments

Global Acute Kidney Injury Treatment Market Outlook

The global acute kidney injury treatment market attained a value of USD 37 billion in 2020. The industry is further expected to grow at a CAGR of 6.1% in the forecast period of 2022-2027 to reach USD 53.1 billion by 2026.

 

Global Acute Kidney Injury Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The increased geriatric population and the growing incidences of acute kidney injury are expected to fuel the growth of the acute kidney injury treatment industry globally. North America is projected to be a leading region in the global acute kidney injury treatment industry due to the increased adoption of advanced technologies in the region.

 

Properties and Applications

The global acute kidney injury treatment industry can be broadly categorised based on segments like types, treatments, end-uses, and regions:

 

Global Acute Kidney Injury Treatment Market By Treatment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Types:
    • Prerenal Acute Kidney Injury 
    • Intrinsic Renal Acute Kidney Injury 
    • Postrenal Acute Kidney Injury 
    • Others
  • Treatments:
    • Dialysis
    • Supportive Care
  • End-Uses:
    • Hospitals
    • Ambulatory Surgical Centres
    • Others

The EMR report looks into the regional markets of acute kidney injury treatment like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Acute Kidney Injury Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The increasing number of dialysis centres is projected to drive the dialysis segment, among other treatment-types, in the acute kidney injury treatment industry. Owing to the strong ongoing clinical pipeline, and the advancements in technology, further supporting more efficient products, the market in North America is anticipated to witness a significant growth in the acute kidney injury treatment industry. Government research and development programmes and initiatives in the healthcare sector are further expected to expand the acute kidney injury treatment industry in the Asia Pacific.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global acute kidney injury treatment industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Angion Biomedica Corp
  • AM-Pharma
  • Quark Pharmaceuticals, Inc
  • Baxter International, Inc. (NYSE: BAX)
  • Fresenius Medical Care AG & Co. KGaA
  • LG Chem Ltd.
  • Asahi Kasei Medical Co., Ltd
  • B. Braun Melsungen AG

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Treatment, End Use, Region
Breakup by Type Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Postrenal Acute Kidney Injury, Others
Breakup by Treatment Dialysis, Supportive Care
Breakup by End Use Hospitals, Ambulatory Surgical Centres, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Angion Biomedica Corp, AM-Pharma, Quark Pharmaceuticals, Inc, Baxter
International, Inc., BAX (NYSE), Fresenius Medical Care AG & Co. KGaA,
FME (ETR), LG Chem Ltd., 051910 (KRX), Asahi Kasei Medical Co., Ltd, B. Braun Melsungen AG
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface        
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Acute Kidney Injury Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Acute Kidney Injury Treatment Historical Market (2017-2021) 
    8.3    Global Acute Kidney Injury Treatment Market Forecast (2022-2027)
    8.4    Global Acute Kidney Injury Treatment Market by Type
        8.4.1    Prerenal Acute Kidney Injury
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Intrinsic Renal Acute Kidney Injury
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Postrenal Acute Kidney Injury
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Others
    8.5    Global Acute Kidney Injury Treatment Market by Treatment
        8.5.1    Dialysis
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Supportive Care
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Acute Kidney Injury Treatment Market by End User
        8.6.1    Hospitals
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Ambulatory Surgical Centres
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Others
    8.7    Global Acute Kidney Injury Treatment Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price  
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Angion
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    AM-Pharma B.V.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Baxter International, Inc. 
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Fresenius Medical Care Holdings, Inc. 
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Asahi Kasei Medical Co., Ltd.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    B. Braun Melsungen AG  
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Acute Kidney Injury Treatment Market: Key Industry Highlights, 2017 and 2027
2.    Global Acute Kidney Injury Treatment Historical Market: Breakup by Type (USD Billion), 2017-2021
3.    Global Acute Kidney Injury Treatment Market Forecast: Breakup by Type (USD Billion), 2022-2027
4.    Global Acute Kidney Injury Treatment Historical Market: Breakup by Treatment (USD Billion), 2017-2021
5.    Global Acute Kidney Injury Treatment Market Forecast: Breakup by Treatment (USD Billion), 2022-2027
6.    Global Acute Kidney Injury Treatment Historical Market: Breakup by End User (USD Billion), 2017-2021
7.    Global Acute Kidney Injury Treatment Market Forecast: Breakup by End User (USD Billion), 2022-2027
8.    Global Acute Kidney Injury Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
9.    Global Acute Kidney Injury Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
10.    North America Acute Kidney Injury Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    North America Acute Kidney Injury Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Europe Acute Kidney Injury Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Europe Acute Kidney Injury Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Asia Pacific Acute Kidney Injury Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Asia Pacific Acute Kidney Injury Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Latin America Acute Kidney Injury Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Latin America Acute Kidney Injury Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Middle East and Africa Acute Kidney Injury Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Middle East and Africa Acute Kidney Injury Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027  
20.    Global Acute Kidney Injury Treatment Market Structure

Key Questions Answered in the Report

In 2020, the global acute kidney injury treatment market attained a value of nearly USD 37 billion.

The market is projected to grow at a CAGR of 6.1% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 53.1 billion by 2026.

The major drivers of the industry, such as the growing prevalence of acute kidney injury, rising demand for improved healthcare facility, favourable government initiatives, growing geriatric population, and rapid technological advancements, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the launch of advanced medical devices and growing research and development activities.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America leading the market. 

Prerenal acute kidney injury, intrinsic renal acute kidney injury, and postrenal acute kidney injury, among others, are the major types in the industry.

The major treatment segments in the market are dialysis and supportive care. 

The significant end use sectors in the industry include hospitals and ambulatory surgical centres, among others. 

The major players in the industry are Angion Biomedica Corp, AM-Pharma, Quark Pharmaceuticals, Inc, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem Ltd., Asahi Kasei Medical Co., Ltd, and B. Braun Melsungen AG.

Analyst Review

The global acute kidney injury treatment market attained a value of USD 37 billion in 2020, driven by the rising incidences of acute kidney injury among the growing geriatric population. Aided by the increased investment in the research and development activities, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 6.1%. The market is projected to reach USD 53.1 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on types, the industry can be segmented into prerenal, intrinsic renal, and postrenal acute kidney injury, among others. On the basis of treatment, the market is bifurcated into dialysis and supportive care. By end use, the industry is divided into hospitals and ambulatory surgical centres, among others. The major regional markets for acute kidney injury treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest market share. The key players in the above market include Angion Biomedica Corp, AM-Pharma, Quark Pharmaceuticals, Inc, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem Ltd., Asahi Kasei Medical Co., Ltd, and B. Braun Melsungen AG.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER